This roundtable will engage the audience in discussion about what it takes to create and maintain a world-class alliance program. Kevin Little, who spearheaded Novo Nordisk's entry and eventual win for the 2021 ASAP Alliance Excellence Awards' Alliance Program Excellence, is in dialogue with the chairman of the Awards Committee, Ard-Pieter de Man, to share insights into his company's particular journey.
Key takeaways for participants focus on:
Ard-Pieter de Man PhD CSAP
Professor of Management Studies
Vrije Universiteit Amsterdam
Ard-Pieter de Man is Professor of Management Studies at the School of Business and Economics at Vrije Universiteit Amsterdam and Dean at Sioo. He is an award-winning (co-) author of over a dozen books and more than fifty articles on alliances, networks and innovation. His specific areas of interest are alliance design and governance, ecosystems and open innovation. His last book Alliances: An executive guide to designing successful strategic partnerships was published by Wiley and is used a handbook by practitioners around the world. Ard-Pieter also works as a consultant and regularly provides alliance advice to both profit and non-profit organizations.
Kevin Little, PhD, CSAP
Senior Director, Partnerships
Kevin oversees the development and management of Novo Nordisk's portfolio of strategic research collaborations in the US across drug discovery, research technologies, and devices.
In the past 15 years he has held various executive roles in the life sciences, always seeking better ways to promote synergies and harness the impact made possible through creative partnering. These include as Chief Scientific Officer of 3D Signatures Inc., as founding executive of Concordia University's PERFORM Centre in preventive health, or leading the New Zealand government's economic development efforts to build strategic investment relationships across the biotechnology industry sector.
Kevin holds a Bachelor of Science degree in Biology from the University of Victoria, and a Ph.D. in Experimental Medicine from McGill University. He completed a postdoctoral fellowship in translational neuroscience and clinical gene therapy at the University of Auckland in New Zealand, and is a Certified Strategic Alliance Professional. He serves on the Accreditation Council of Human Research Accreditation Canada, and on the Technical Committee developing the Canadian Standard for Conduct of Human Research.